Literature DB >> 3490017

Effect of interleukin 1 on chemotaxis and chemiluminescence of human neutrophils.

T Terui, T Kato, R Suzuki, K Kumagai, H Tagami.   

Abstract

We studied the influence of interleukin 1 (IL 1) on chemotaxis and chemiluminescence (CL) of human neutrophils. We found that IL 1 showed chemotactic activity within the concentrations ranging from 1 to 200 U/ml, whereas no luminol-or lucigenin-dependent CL was noted in neutrophils with the stimulation of IL 1 at the concentrations ranged from 1 to 100 U/ml. Moreover, no enhancement of zymosan-induced CL was observed in neutrophils following prior exposure to IL 1 at a concentration of 100 U/ml for 60 min at 37 degrees C. We think that IL 1 may be responsible for the inflammatory reaction only through its chemotactic activity for neutrophils without enhancement of the oxidative metabolism of neutrophils.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490017     DOI: 10.1620/tjem.149.317

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  4 in total

1.  Aberrant phagocyte function in Shwachman syndrome.

Authors:  H Repo; E Savilahti; M Leirisalo-Repo
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

2.  Recombinant interleukin-1 beta interacts with high-affinity receptors to activate neutrophil leukotriene B4 synthesis.

Authors:  L Borish; R Rosenbaum; B McDonald; L J Rosenwasser
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

3.  Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease.

Authors:  Y Niwa; Y Mizushima
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

4.  Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors.

Authors:  B Z Joseph; J M Routes; L Borish
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.